A prospective randomized controlled trial of point-of-care testing on the coronary care unit

Background: We report the results of a prospective randomized controlled trial comparing point-of-care testing (POCT) with central laboratory testing (CLT) in a six-bed coronary care unit in a district general hospital. Methods: 263 consecutive admissions with chest pain and suspected acute coronary syndrome were randomized to measurement of cardiac troponin T by POCT or CLT only. Patient management was according to a pre-specified protocol utilizing clinical features, electrocardiographic changes and cardiac biomarkers (creatine kinase and cardiac troponin T) to define management. Outcome measures were diagnostic accuracy compared with CLT as 'gold standard', result turnaround time, mortality and length of stay in all patients and those with a protocol-driven early discharge policy. Results: Diagnostic accuracy and mortality was equivalent in the POCT and CLT arm. Overall there was no difference in length of stay. In the pre-specified early discharge group (n = 64) there was a significant reduction in median length of non-coronary care unit stay (145.3 h versus 79.5 h) and overall hospital stay (209.3 h versus 149.9 h) in those randomized to POCT. Conclusion: A combination of rapid biochemical diagnosis and structured decisionmaking reduces length of hospital stay.

[1]  H. Thode,et al.  Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction. , 1997, Clinics in Laboratory Medicine.

[2]  James McCord,et al.  Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I , 2001, Circulation.

[3]  S J Steindel,et al.  Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. , 1998, Clinical chemistry.

[4]  R. Fitzgerald,et al.  Ninety-minute accelerated critical pathway for chest pain evaluation. , 2001, The American journal of cardiology.

[5]  J W Winkelman,et al.  How fast is fast enough for clinical laboratory turnaround time? Measurement of the interval between result entry and inquiries for reports. , 1997, American journal of clinical pathology.

[6]  Hugo A. Katus,et al.  Evaluation of a Point-of-Care System for Quantitative Determination of Troponin T and Myoglobin , 2000, Clinical chemistry and laboratory medicine.

[7]  R. Christenson,et al.  Multisite Study of a Second Generation Whole Blood Rapid Assay for Cardiac Troponin T , 1999, Annals of clinical biochemistry.

[8]  R H Christenson,et al.  Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. , 1999, Clinical chemistry.

[9]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[10]  M. Clancy,et al.  Point of care testing: randomised controlled trial of clinical outcome , 1998, BMJ.

[11]  C. Sylvén,et al.  Recalibration of the point-of-care test for CARDIAC T Quantitative with Elecsys Troponin T 3rd generation. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[12]  C A Parvin,et al.  Impact of point-of-care testing on patients' length of stay in a large emergency department. , 1996, Clinical chemistry.

[13]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[14]  A. Jaffe,et al.  Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. , 2001, Circulation.

[15]  G. Sandler Aeromonas spp in diarrhoea. , 1984, British medical journal.

[16]  C. Sylvén,et al.  Analytical and clinical performance of an improved qualitative troponin T rapid test in laboratories and critical care units. , 2009, Archives of pathology & laboratory medicine.

[17]  P. Collinson,et al.  Troponin T for the Differential Diagnosis of Ischaemic Myocardial Damage , 1993, Annals of clinical biochemistry.

[18]  R. CANEPA-ANSON,et al.  Rapid Troponin T Measurement in Whole Blood for Detection of Myocardial Damage , 1995, Annals of clinical biochemistry.

[19]  P. Collinson,et al.  Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. , 2000, Clinical chemistry.

[20]  P. Collinson,et al.  Rapid Enzyme Diagnosis of Patients with Acute Chest Pain Reduces Patient Stay in the Coronary Care Unit , 1993, Annals of clinical biochemistry.

[21]  P. Collinson,et al.  The need for a point of care testing: an evidence-based appraisal. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[22]  J. Hampton,et al.  Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. , 1975, British medical journal.